Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.


Psoriasis treatments can be life-changing

If you suffer from psoriasis, vibrant, clear skin is no longer out of reach. According to Rush dermatologists, new innovative treatments can help you put your best face forward.

page 1 from 11